Cryomass Technologies (Cryomass Technologies) Cash And Cash Equivalents : $0.01 Mil (As of Sep. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Cryomass Technologies Cash And Cash Equivalents?

Cryomass Technologies's quarterly cash and cash equivalents declined from Mar. 2023 ($0.66 Mil) to Jun. 2023 ($0.32 Mil) but then stayed the same from Jun. 2023 ($0.32 Mil) to Sep. 2023 ($0.01 Mil).

Cryomass Technologies's annual cash and cash equivalents increased from Dec. 2020 ($0.33 Mil) to Dec. 2021 ($5.77 Mil) but then declined from Dec. 2021 ($5.77 Mil) to Dec. 2022 ($2.02 Mil).

Cryomass Technologies Cash And Cash Equivalents Historical Data

The historical data trend for Cryomass Technologies's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cryomass Technologies Cash And Cash Equivalents Chart

Cryomass Technologies Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Cash And Cash Equivalents

Get a 7-Day Free Trial

0.17

3.47

0.33

5.77

2.02

Cryomass Technologies Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Cash And Cash Equivalents	Get a 7-Day Free Trial															3.13	2.02	0.66	0.32	0.01

Cryomass Technologies Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Cryomass Technologies (OTCPK:CRYM) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Cryomass Technologies Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Cryomass Technologies's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Cryomass Technologies (Cryomass Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cryomass Technologies Inc (OTCPK:CRYM) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

N/A

Address

1001 Bannock Street, Suite 612, Denver, CO, USA, 80204

Website

https://www.cryomass.com

Cryomass Technologies Inc designs, manufactures, and licenses field-mobile equipment for the handling of harvested cannabis, hemp, and other high-value plant material. The company owns patented technology that utilizes liquid nitrogen to fully separate, collect and protect the high-value compounds from the harvested plant. The company's offerings include refinement systems and monitoring and control systems.

Executives

Philip Blair Mullin	officer: Chief Financial Officer	3531 SOUTH LOGAN STREET, SUITE D-357, ENGLEWOOD CO 80113
Christian Noel	director, officer: Chief Executive Officer	3531 SOUTH LOGAN ST. SUITE D-357, ENGLEWOOD CO 80113
Patricia Izabel Kovacevic	officer: GC, Corp Secy, and Head of EA	3531 SOUTH LOGAN STREET, SUITE D-357, ENGLEWOOD CO 80113
Delon Hannes Human	director	3531 SOUTH LOGAN STREET, SUITE D-357, ENGLEWOOD CO 80113
Mark Radke	director	3531 SOUTH LOGAN STREET, SUITE D-357, ENGLEWOOD CO 80113
Mario Gobbo	director	3531 SOUTH LOGAN STREET, SUITE D-357, ENGLEWOOD CO 80113